Cargando…
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Sc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647649/ https://www.ncbi.nlm.nih.gov/pubmed/35940234 http://dx.doi.org/10.1016/j.ihj.2022.07.009 |
_version_ | 1784827420549840896 |
---|---|
author | Misra, Sanjana Lyngdoh, Tanica Mulchandani, Rubina |
author_facet | Misra, Sanjana Lyngdoh, Tanica Mulchandani, Rubina |
author_sort | Misra, Sanjana |
collection | PubMed |
description | Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Scholar, Cochrane Library and Science Direct to obtain relevant articles. Dyslipidemia management guidelines by western medical associations are based on their studies, with ethnic minorities underrepresented and biological features of other racial groups inadequately incorporated. The Lipid Association of India (LAI) came up with a consensus statement guided by an expert panel to adapt the western guidelines to Indians. However, absence of Indian guidelines has led to physicians basing treatment on individual preference, contributing to heterogeneity. Our review underscores the need for formulating Indian dyslipidemia management guidelines and CV risk estimation algorithms, highlighting the scope for further research. This could supplement the clinical expertise of LAI and enhance patient experience. |
format | Online Article Text |
id | pubmed-9647649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96476492022-11-15 Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research Misra, Sanjana Lyngdoh, Tanica Mulchandani, Rubina Indian Heart J Review Article Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Scholar, Cochrane Library and Science Direct to obtain relevant articles. Dyslipidemia management guidelines by western medical associations are based on their studies, with ethnic minorities underrepresented and biological features of other racial groups inadequately incorporated. The Lipid Association of India (LAI) came up with a consensus statement guided by an expert panel to adapt the western guidelines to Indians. However, absence of Indian guidelines has led to physicians basing treatment on individual preference, contributing to heterogeneity. Our review underscores the need for formulating Indian dyslipidemia management guidelines and CV risk estimation algorithms, highlighting the scope for further research. This could supplement the clinical expertise of LAI and enhance patient experience. Elsevier 2022 2022-08-05 /pmc/articles/PMC9647649/ /pubmed/35940234 http://dx.doi.org/10.1016/j.ihj.2022.07.009 Text en © 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Misra, Sanjana Lyngdoh, Tanica Mulchandani, Rubina Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title | Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title_full | Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title_fullStr | Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title_full_unstemmed | Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title_short | Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research |
title_sort | guidelines for dyslipidemia management in india: a review of the current scenario and gaps in research |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647649/ https://www.ncbi.nlm.nih.gov/pubmed/35940234 http://dx.doi.org/10.1016/j.ihj.2022.07.009 |
work_keys_str_mv | AT misrasanjana guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch AT lyngdohtanica guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch AT mulchandanirubina guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch |